Search for: "Amgen, Inc.. v. Hospira, Inc.."
Results 1 - 20
of 26
Sorted by Relevance
|
Sort by Date
10 Aug 2017, 9:58 pm
" trilogy of BPCIA Federal Circuit cases, the Court in Amgen Inc. v. [read post]
30 Aug 2018, 9:59 pm
District Court Judge for the District of Delaware decided a veritable plethora of post-trial motions (by both parties) in Amgen Inc. v. [read post]
18 Dec 2019, 9:59 pm
For example, in Classen Immunotherapies, Inc. v. [read post]
9 Jan 2021, 9:16 am
Connolly, in Amgen Inc. et al. v. [read post]
11 Aug 2017, 6:06 am
” Order, Amgen, Inc. v. [read post]
18 Aug 2017, 2:15 am
Amgen Inc. v. [read post]
14 Dec 2014, 9:59 pm
Amgen Inc. [read post]
18 Aug 2017, 2:15 am
Amgen Inc. v. [read post]
3 Dec 2016, 7:52 am
Andrews in Amgen Inc. v. [read post]
12 Dec 2014, 10:29 pm
SeeAmgen Inc. v. [read post]
16 Aug 2017, 8:21 am
” Sandoz, Inc. v. [read post]
22 Nov 2019, 10:32 am
Hospira, Inc., 933 F.3d 1320 (Fed. [read post]
9 Aug 2016, 7:50 am
" Amgen Inc. et al v. [read post]
6 Apr 2017, 1:35 pm
Hospira,Inc., 791 F.3d 1368, 1372 (Fed. [read post]
19 Mar 2014, 9:00 am
It has been 15 years since the last brand v brand challenge of a biologic patent in Canada. [read post]
18 Apr 2016, 9:58 am
Hospira, Inc., No. 15-1210 (bright line limits on secondary indicia of nonobviousness) [CubistPetition] Post Grant Admin: Versata v. [read post]
3 Jun 2016, 6:40 am
Hospira, Inc., No. 15-1210 (bright line limits on secondary indicia of nonobviousness) [CubistPetition] Vehicle Intelligence and Safety LLC v. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
18 May 2016, 8:19 am
Hospira, Inc., No. 15-1210 (bright line limits on secondary indicia of nonobviousness) [CubistPetition] Post Grant Admin: MCM v. [read post]
1 Apr 2016, 8:22 am
Hospira, Inc., No. 15-1210 (bright line limits on secondary indicia of nonobviousness) [CubistPetition] Infringement by Joint Enterprise: Limelight Networks, Inc. v. [read post]
